

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.18848275 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.18848275 |
| 3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.98257560 |
| 4 | negative regulation of cell killing (GO:0031342) | 3.98257560 |
| 5 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.74368866 |
| 6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.55489928 |
| 7 | protein carboxylation (GO:0018214) | 3.55112441 |
| 8 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.55112441 |
| 9 | detection of other organism (GO:0098543) | 3.42717735 |
| 10 | apoptotic cell clearance (GO:0043277) | 3.39099276 |
| 11 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.34624286 |
| 12 | positive regulation by symbiont of host defense response (GO:0052509) | 3.29060652 |
| 13 | modulation by symbiont of host defense response (GO:0052031) | 3.29060652 |
| 14 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.29060652 |
| 15 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.29060652 |
| 16 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.29060652 |
| 17 | modulation by symbiont of host immune response (GO:0052553) | 3.29060652 |
| 18 | detection of bacterium (GO:0016045) | 3.26930295 |
| 19 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 3.14015751 |
| 20 | complement activation, alternative pathway (GO:0006957) | 3.05415497 |
| 21 | negative regulation of phagocytosis (GO:0050765) | 3.03086561 |
| 22 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.00301158 |
| 23 | mannose metabolic process (GO:0006013) | 2.99067577 |
| 24 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.97641515 |
| 25 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.96819782 |
| 26 | macrophage activation involved in immune response (GO:0002281) | 2.93279061 |
| 27 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.85693162 |
| 28 | endodermal cell differentiation (GO:0035987) | 2.80971107 |
| 29 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.79979229 |
| 30 | barbed-end actin filament capping (GO:0051016) | 2.79743337 |
| 31 | cell adhesion mediated by integrin (GO:0033627) | 2.79040134 |
| 32 | pinocytosis (GO:0006907) | 2.78062738 |
| 33 | germinal center formation (GO:0002467) | 2.77956254 |
| 34 | low-density lipoprotein particle clearance (GO:0034383) | 2.76610500 |
| 35 | detection of biotic stimulus (GO:0009595) | 2.75856799 |
| 36 | response to laminar fluid shear stress (GO:0034616) | 2.75713877 |
| 37 | regulation of protein activation cascade (GO:2000257) | 2.71901774 |
| 38 | regulation of complement activation (GO:0030449) | 2.70051009 |
| 39 | cellular extravasation (GO:0045123) | 2.69809213 |
| 40 | detection of molecule of bacterial origin (GO:0032490) | 2.68674971 |
| 41 | negative thymic T cell selection (GO:0045060) | 2.68418414 |
| 42 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.66680903 |
| 43 | protein localization to endosome (GO:0036010) | 2.66182867 |
| 44 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.65378567 |
| 45 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.63875058 |
| 46 | positive regulation of p38MAPK cascade (GO:1900745) | 2.63136438 |
| 47 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.62025274 |
| 48 | regulation of T cell tolerance induction (GO:0002664) | 2.61075787 |
| 49 | regulation of apoptotic cell clearance (GO:2000425) | 2.58936993 |
| 50 | regulation of extracellular matrix disassembly (GO:0010715) | 2.58496971 |
| 51 | regulation of cholesterol storage (GO:0010885) | 2.57368062 |
| 52 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.56520389 |
| 53 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.56520389 |
| 54 | response to muramyl dipeptide (GO:0032495) | 2.56481031 |
| 55 | negative T cell selection (GO:0043383) | 2.53207735 |
| 56 | regulation of tolerance induction (GO:0002643) | 2.52459354 |
| 57 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.52191825 |
| 58 | negative regulation of granulocyte differentiation (GO:0030853) | 2.52112653 |
| 59 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.51625109 |
| 60 | hypotonic response (GO:0006971) | 2.51466277 |
| 61 | response to fluid shear stress (GO:0034405) | 2.50832811 |
| 62 | regulation of leukocyte degranulation (GO:0043300) | 2.50400573 |
| 63 | positive regulation of sterol transport (GO:0032373) | 2.48450757 |
| 64 | positive regulation of cholesterol transport (GO:0032376) | 2.48450757 |
| 65 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.48270507 |
| 66 | response to type I interferon (GO:0034340) | 2.48162604 |
| 67 | growth hormone receptor signaling pathway (GO:0060396) | 2.48021970 |
| 68 | immunoglobulin mediated immune response (GO:0016064) | 2.47784997 |
| 69 | basement membrane organization (GO:0071711) | 2.47692717 |
| 70 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.46560442 |
| 71 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.46068762 |
| 72 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.45597618 |
| 73 | type I interferon signaling pathway (GO:0060337) | 2.45321075 |
| 74 | cellular response to type I interferon (GO:0071357) | 2.45321075 |
| 75 | phospholipid efflux (GO:0033700) | 2.45319705 |
| 76 | regulation of macrophage cytokine production (GO:0010935) | 2.45030939 |
| 77 | plasma lipoprotein particle clearance (GO:0034381) | 2.43935756 |
| 78 | positive regulation of cholesterol efflux (GO:0010875) | 2.43788140 |
| 79 | B cell receptor signaling pathway (GO:0050853) | 2.43344607 |
| 80 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.42630793 |
| 81 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.42363878 |
| 82 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.41901345 |
| 83 | protein heterotrimerization (GO:0070208) | 2.41602237 |
| 84 | phospholipid homeostasis (GO:0055091) | 2.40832726 |
| 85 | negative regulation of fibrinolysis (GO:0051918) | 2.40554199 |
| 86 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.40269440 |
| 87 | stress fiber assembly (GO:0043149) | 2.39502163 |
| 88 | neutrophil mediated immunity (GO:0002446) | 2.39281461 |
| 89 | neutrophil activation involved in immune response (GO:0002283) | 2.38789612 |
| 90 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.38227703 |
| 91 | thymic T cell selection (GO:0045061) | 2.37850598 |
| 92 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.37661966 |
| 93 | regulation of mast cell degranulation (GO:0043304) | 2.37429104 |
| 94 | positive regulation of B cell differentiation (GO:0045579) | 2.37302489 |
| 95 | defense response to fungus (GO:0050832) | 2.37223698 |
| 96 | negative regulation of interleukin-12 production (GO:0032695) | 2.36850500 |
| 97 | response to peptidoglycan (GO:0032494) | 2.36810732 |
| 98 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.36342491 |
| 99 | response to interleukin-15 (GO:0070672) | 2.35522947 |
| 100 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.35519756 |
| 101 | negative regulation of stress fiber assembly (GO:0051497) | 2.35501564 |
| 102 | T cell selection (GO:0045058) | 2.35414971 |
| 103 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.35342886 |
| 104 | germ cell migration (GO:0008354) | 2.35239119 |
| 105 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.35178279 |
| 106 | positive regulation of histone deacetylation (GO:0031065) | 2.34774100 |
| 107 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.33028579 |
| 108 | regulation of gamma-delta T cell activation (GO:0046643) | 2.32618246 |
| 109 | positive regulation of receptor recycling (GO:0001921) | 2.32553094 |
| 110 | response to fungus (GO:0009620) | 2.32486149 |
| 111 | regulation of phagocytosis (GO:0050764) | 2.31464498 |
| 112 | leukocyte aggregation (GO:0070486) | 2.31157051 |
| 113 | positive regulation of tolerance induction (GO:0002645) | 2.30795243 |
| 114 | regulation of necroptotic process (GO:0060544) | 2.30258381 |
| 115 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.29643541 |
| 116 | alpha-linolenic acid metabolic process (GO:0036109) | 2.28706021 |
| 117 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.28619053 |
| 118 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.28597295 |
| 119 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.28595229 |
| 120 | positive regulation of blood coagulation (GO:0030194) | 2.28480909 |
| 121 | positive regulation of hemostasis (GO:1900048) | 2.28480909 |
| 122 | positive regulation of extracellular matrix organization (GO:1903055) | 2.28232287 |
| 123 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.27160464 |
| 124 | skin morphogenesis (GO:0043589) | 2.26505411 |
| 125 | positive regulation of interferon-alpha production (GO:0032727) | 2.26378068 |
| 126 | negative regulation of T cell mediated immunity (GO:0002710) | 2.25838718 |
| 127 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.25693945 |
| 128 | urea cycle (GO:0000050) | 2.24937496 |
| 129 | urea metabolic process (GO:0019627) | 2.24937496 |
| 130 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.23472794 |
| 131 | response to interferon-alpha (GO:0035455) | 2.23413015 |
| 132 | negative regulation of fatty acid transport (GO:2000192) | 2.22780109 |
| 133 | collagen metabolic process (GO:0032963) | 2.22338128 |
| 134 | negative regulation of innate immune response (GO:0045824) | 2.22106083 |
| 135 | positive thymic T cell selection (GO:0045059) | 2.22062509 |
| 136 | NIK/NF-kappaB signaling (GO:0038061) | 2.21333804 |
| 137 | positive regulation of lipid catabolic process (GO:0050996) | 2.21324002 |
| 138 | blood vessel maturation (GO:0001955) | 2.21210411 |
| 139 | response to host (GO:0075136) | 2.20954186 |
| 140 | response to host defenses (GO:0052200) | 2.20954186 |
| 141 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.20954186 |
| 142 | macrophage activation (GO:0042116) | 2.20736632 |
| 143 | myeloid dendritic cell differentiation (GO:0043011) | 2.20323755 |
| 144 | adhesion of symbiont to host cell (GO:0044650) | 2.20149621 |
| 145 | virion attachment to host cell (GO:0019062) | 2.20149621 |
| 146 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.19884360 |
| 147 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.19853592 |
| 148 | regulation of fibrinolysis (GO:0051917) | 2.19548155 |
| 149 | embryonic process involved in female pregnancy (GO:0060136) | 2.19265019 |
| 150 | collagen fibril organization (GO:0030199) | 2.19249154 |
| 151 | cortical actin cytoskeleton organization (GO:0030866) | 2.19144966 |
| 152 | collagen catabolic process (GO:0030574) | 2.18922127 |
| 153 | I-kappaB phosphorylation (GO:0007252) | 2.18818113 |
| 154 | tolerance induction (GO:0002507) | 2.18108878 |
| 155 | myeloid cell activation involved in immune response (GO:0002275) | 2.17765755 |
| 156 | response to host immune response (GO:0052572) | 2.17556388 |
| 157 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.17556388 |
| 158 | angiogenesis involved in wound healing (GO:0060055) | 2.17516036 |
| 159 | fibrinolysis (GO:0042730) | 2.17310371 |
| 160 | positive regulation of coagulation (GO:0050820) | 2.17170468 |
| 161 | detection of external biotic stimulus (GO:0098581) | 2.16673485 |
| 162 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.16104340 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.86099107 |
| 2 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.32132640 |
| 3 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.29749354 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.25041768 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.23571385 |
| 6 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.13279400 |
| 7 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.06449782 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.95214606 |
| 9 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.90413021 |
| 10 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.69935573 |
| 11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.68993132 |
| 12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.67585863 |
| 13 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.65960909 |
| 14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.53383791 |
| 15 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.53013245 |
| 16 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.51381344 |
| 17 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.45396656 |
| 18 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.45376671 |
| 19 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.41398667 |
| 20 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.41134955 |
| 21 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.39396315 |
| 22 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.36874978 |
| 23 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.21388784 |
| 24 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.16987487 |
| 25 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.16658825 |
| 26 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.15713984 |
| 27 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.11220271 |
| 28 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.00369841 |
| 29 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.00186215 |
| 30 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.00180766 |
| 31 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.99677500 |
| 32 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.90112743 |
| 33 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.88608419 |
| 34 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.87560054 |
| 35 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.85647200 |
| 36 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.77363837 |
| 37 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.74154932 |
| 38 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.72003093 |
| 39 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.71892758 |
| 40 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.71305361 |
| 41 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.71025655 |
| 42 | MAF_26560356_Chip-Seq_TH1_Human | 1.67078845 |
| 43 | GATA1_22025678_ChIP-Seq_K562_Human | 1.66961584 |
| 44 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.65849351 |
| 45 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.61492552 |
| 46 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58819168 |
| 47 | MYC_22102868_ChIP-Seq_BL_Human | 1.58645438 |
| 48 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.57972097 |
| 49 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.56468565 |
| 50 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.50914168 |
| 51 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.49487238 |
| 52 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.45398570 |
| 53 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.43308303 |
| 54 | SPI1_23127762_ChIP-Seq_K562_Human | 1.41722967 |
| 55 | UTX_26944678_Chip-Seq_JUKART_Human | 1.40348548 |
| 56 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.40175659 |
| 57 | GATA1_19941826_ChIP-Seq_K562_Human | 1.37746398 |
| 58 | MYB_26560356_Chip-Seq_TH2_Human | 1.37139338 |
| 59 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.34615312 |
| 60 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.33841334 |
| 61 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.33546667 |
| 62 | MYB_26560356_Chip-Seq_TH1_Human | 1.31915049 |
| 63 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.29897932 |
| 64 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.29539946 |
| 65 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.29487680 |
| 66 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.28458159 |
| 67 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.27753574 |
| 68 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.27558626 |
| 69 | MAF_26560356_Chip-Seq_TH2_Human | 1.27352990 |
| 70 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.27271663 |
| 71 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.26600358 |
| 72 | GATA2_19941826_ChIP-Seq_K562_Human | 1.25625515 |
| 73 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.25425882 |
| 74 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.24825005 |
| 75 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.22791374 |
| 76 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.21926549 |
| 77 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.21778718 |
| 78 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.20823436 |
| 79 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.19895946 |
| 80 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.19618242 |
| 81 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.18267768 |
| 82 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.17981464 |
| 83 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.17577278 |
| 84 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14955512 |
| 85 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13941071 |
| 86 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12631427 |
| 87 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.12405881 |
| 88 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12028110 |
| 89 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.10355706 |
| 90 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09190620 |
| 91 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.08926875 |
| 92 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.05836716 |
| 93 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.04738308 |
| 94 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.04738308 |
| 95 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.03481339 |
| 96 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.03386238 |
| 97 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.02554346 |
| 98 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.02281402 |
| 99 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.01246498 |
| 100 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00471844 |
| 101 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.99894790 |
| 102 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98751505 |
| 103 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.97984335 |
| 104 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.97923984 |
| 105 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96820435 |
| 106 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.96090279 |
| 107 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.95937383 |
| 108 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.95501851 |
| 109 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.95324031 |
| 110 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94894659 |
| 111 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.94415617 |
| 112 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.94293743 |
| 113 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94279515 |
| 114 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.93684312 |
| 115 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.92062061 |
| 116 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.91533459 |
| 117 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.91529496 |
| 118 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.91529496 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 4.03022493 |
| 2 | MP0003705_abnormal_hypodermis_morpholog | 3.24755888 |
| 3 | MP0005275_abnormal_skin_tensile | 2.48053870 |
| 4 | MP0003300_gastrointestinal_ulcer | 2.33313454 |
| 5 | MP0009278_abnormal_bone_marrow | 2.23126174 |
| 6 | MP0003724_increased_susceptibility_to | 2.19402961 |
| 7 | MP0003303_peritoneal_inflammation | 2.18007537 |
| 8 | MP0003436_decreased_susceptibility_to | 2.17904458 |
| 9 | MP0003279_aneurysm | 1.98187867 |
| 10 | MP0009840_abnormal_foam_cell | 1.90514606 |
| 11 | MP0001958_emphysema | 1.88136837 |
| 12 | MP0002419_abnormal_innate_immunity | 1.81318888 |
| 13 | MP0001545_abnormal_hematopoietic_system | 1.81039480 |
| 14 | MP0005397_hematopoietic_system_phenotyp | 1.81039480 |
| 15 | MP0003566_abnormal_cell_adhesion | 1.80812723 |
| 16 | MP0005451_abnormal_body_composition | 1.79860413 |
| 17 | MP0002166_altered_tumor_susceptibility | 1.77851752 |
| 18 | MP0005503_abnormal_tendon_morphology | 1.77561527 |
| 19 | MP0002139_abnormal_hepatobiliary_system | 1.77206236 |
| 20 | MP0001835_abnormal_antigen_presentation | 1.76976176 |
| 21 | MP0005360_urolithiasis | 1.75689955 |
| 22 | MP0003191_abnormal_cellular_cholesterol | 1.74702588 |
| 23 | MP0005058_abnormal_lysosome_morphology | 1.71963476 |
| 24 | MP0006054_spinal_hemorrhage | 1.71388231 |
| 25 | MP0000685_abnormal_immune_system | 1.71350027 |
| 26 | MP0005464_abnormal_platelet_physiology | 1.71255865 |
| 27 | MP0002254_reproductive_system_inflammat | 1.67208258 |
| 28 | MP0005023_abnormal_wound_healing | 1.66710490 |
| 29 | MP0002060_abnormal_skin_morphology | 1.63575476 |
| 30 | MP0009785_altered_susceptibility_to | 1.62698746 |
| 31 | MP0000569_abnormal_digit_pigmentation | 1.58430282 |
| 32 | MP0010368_abnormal_lymphatic_system | 1.56654936 |
| 33 | MP0001533_abnormal_skeleton_physiology | 1.54897434 |
| 34 | MP0004947_skin_inflammation | 1.54605787 |
| 35 | MP0005025_abnormal_response_to | 1.53155651 |
| 36 | MP0010352_gastrointestinal_tract_polyps | 1.49615973 |
| 37 | MP0005365_abnormal_bile_salt | 1.39240833 |
| 38 | MP0002396_abnormal_hematopoietic_system | 1.37607101 |
| 39 | MP0010329_abnormal_lipoprotein_level | 1.36826898 |
| 40 | MP0008260_abnormal_autophagy | 1.36259587 |
| 41 | MP0003252_abnormal_bile_duct | 1.36250116 |
| 42 | MP0000343_altered_response_to | 1.34273816 |
| 43 | MP0005076_abnormal_cell_differentiation | 1.33991303 |
| 44 | MP0002006_tumorigenesis | 1.33943898 |
| 45 | MP0006082_CNS_inflammation | 1.32864407 |
| 46 | MP0001790_abnormal_immune_system | 1.31266872 |
| 47 | MP0005387_immune_system_phenotype | 1.31266872 |
| 48 | MP0004272_abnormal_basement_membrane | 1.31037417 |
| 49 | MP0000767_abnormal_smooth_muscle | 1.27818416 |
| 50 | MP0005000_abnormal_immune_tolerance | 1.25526549 |
| 51 | MP0002998_abnormal_bone_remodeling | 1.23426733 |
| 52 | MP0002452_abnormal_antigen_presenting | 1.22361643 |
| 53 | MP0000465_gastrointestinal_hemorrhage | 1.22254113 |
| 54 | MP0004883_abnormal_blood_vessel | 1.21415823 |
| 55 | MP0000604_amyloidosis | 1.21240579 |
| 56 | MP0001800_abnormal_humoral_immune | 1.20236873 |
| 57 | MP0005085_abnormal_gallbladder_physiolo | 1.19051383 |
| 58 | MP0004808_abnormal_hematopoietic_stem | 1.15503147 |
| 59 | MP0001243_abnormal_dermal_layer | 1.14382379 |
| 60 | MP0002405_respiratory_system_inflammati | 1.13703729 |
| 61 | MP0005167_abnormal_blood-brain_barrier | 1.13321803 |
| 62 | MP0000858_altered_metastatic_potential | 1.12652099 |
| 63 | MP0001845_abnormal_inflammatory_respons | 1.12619732 |
| 64 | MP0005671_abnormal_response_to | 1.11315002 |
| 65 | MP0002398_abnormal_bone_marrow | 1.11244111 |
| 66 | MP0009764_decreased_sensitivity_to | 1.11211958 |
| 67 | MP0003448_altered_tumor_morphology | 1.11056047 |
| 68 | MP0010155_abnormal_intestine_physiology | 1.08991164 |
| 69 | MP0001879_abnormal_lymphatic_vessel | 1.08615744 |
| 70 | MP0003091_abnormal_cell_migration | 1.08614387 |
| 71 | MP0000609_abnormal_liver_physiology | 1.07726468 |
| 72 | MP0003075_altered_response_to | 1.07601266 |
| 73 | MP0002420_abnormal_adaptive_immunity | 1.07022927 |
| 74 | MP0001873_stomach_inflammation | 1.06985063 |
| 75 | MP0002148_abnormal_hypersensitivity_rea | 1.06864051 |
| 76 | MP0001819_abnormal_immune_cell | 1.06618928 |
| 77 | MP0004510_myositis | 1.04739033 |
| 78 | MP0002723_abnormal_immune_serum | 1.04676175 |
| 79 | MP0008469_abnormal_protein_level | 1.04296460 |
| 80 | MP0003453_abnormal_keratinocyte_physiol | 1.03463020 |
| 81 | MP0001851_eye_inflammation | 1.03368816 |
| 82 | MP0005083_abnormal_biliary_tract | 1.03337029 |
| 83 | MP0008004_abnormal_stomach_pH | 1.03313243 |
| 84 | MP0001849_ear_inflammation | 1.02660421 |
| 85 | MP0005390_skeleton_phenotype | 1.01522653 |
| 86 | MP0004185_abnormal_adipocyte_glucose | 1.01101239 |
| 87 | MP0005257_abnormal_intraocular_pressure | 1.00763976 |
| 88 | MP0005409_darkened_coat_color | 1.00214732 |
| 89 | MP0003172_abnormal_lysosome_physiology | 0.98164114 |
| 90 | MP0010307_abnormal_tumor_latency | 0.97596849 |
| 91 | MP0001542_abnormal_bone_strength | 0.97291806 |
| 92 | MP0002138_abnormal_hepatobiliary_system | 0.97008695 |
| 93 | MP0009384_cardiac_valve_regurgitation | 0.95242212 |
| 94 | MP0001853_heart_inflammation | 0.95201990 |
| 95 | MP0002933_joint_inflammation | 0.94686552 |
| 96 | MP0003828_pulmonary_edema | 0.94054099 |
| 97 | MP0002722_abnormal_immune_system | 0.93756274 |
| 98 | MP0000249_abnormal_blood_vessel | 0.93272718 |
| 99 | MP0005164_abnormal_response_to | 0.91079607 |
| 100 | MP0003183_abnormal_peptide_metabolism | 0.90669686 |
| 101 | MP0009763_increased_sensitivity_to | 0.90221537 |
| 102 | MP0002429_abnormal_blood_cell | 0.90075061 |
| 103 | MP0003690_abnormal_glial_cell | 0.88692638 |
| 104 | MP0003866_abnormal_defecation | 0.87840629 |
| 105 | MP0002877_abnormal_melanocyte_morpholog | 0.87610998 |
| 106 | MP0001915_intracranial_hemorrhage | 0.87493409 |
| 107 | MP0000689_abnormal_spleen_morphology | 0.86830292 |
| 108 | MP0003656_abnormal_erythrocyte_physiolo | 0.86397319 |
| 109 | MP0005666_abnormal_adipose_tissue | 0.86046964 |
| 110 | MP0003795_abnormal_bone_structure | 0.85895213 |
| 111 | MP0009333_abnormal_splenocyte_physiolog | 0.83880949 |
| 112 | MP0002132_abnormal_respiratory_system | 0.83272761 |
| 113 | MP0003763_abnormal_thymus_physiology | 0.83097835 |
| 114 | MP0008875_abnormal_xenobiotic_pharmacok | 0.82959775 |
| 115 | MP0003045_fibrosis | 0.82479861 |
| 116 | MP0005670_abnormal_white_adipose | 0.81868387 |
| 117 | MP0004130_abnormal_muscle_cell | 0.81773657 |
| 118 | MP0005166_decreased_susceptibility_to | 0.81333156 |
| 119 | MP0000703_abnormal_thymus_morphology | 0.81011422 |
| 120 | MP0002295_abnormal_pulmonary_circulatio | 0.80851836 |
| 121 | MP0009115_abnormal_fat_cell | 0.80710316 |
| 122 | MP0000716_abnormal_immune_system | 0.80383165 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protrusio acetabuli (HP:0003179) | 4.16466855 |
| 2 | Eczematoid dermatitis (HP:0000976) | 3.59851037 |
| 3 | Broad metatarsal (HP:0001783) | 3.47575059 |
| 4 | Peritonitis (HP:0002586) | 3.42131908 |
| 5 | Cerebral aneurysm (HP:0004944) | 3.41443766 |
| 6 | Deep venous thrombosis (HP:0002625) | 3.33894903 |
| 7 | Hematochezia (HP:0002573) | 3.27321110 |
| 8 | Premature rupture of membranes (HP:0001788) | 3.27138458 |
| 9 | Complement deficiency (HP:0004431) | 3.25876431 |
| 10 | Ankle contracture (HP:0006466) | 3.25781156 |
| 11 | Systemic lupus erythematosus (HP:0002725) | 3.25018962 |
| 12 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.23204670 |
| 13 | Aortic dissection (HP:0002647) | 3.22203923 |
| 14 | Spontaneous hematomas (HP:0007420) | 3.08844903 |
| 15 | Aortic aneurysm (HP:0004942) | 2.88364319 |
| 16 | Myocardial infarction (HP:0001658) | 2.85356137 |
| 17 | Periodontitis (HP:0000704) | 2.84188542 |
| 18 | Recurrent abscess formation (HP:0002722) | 2.83642338 |
| 19 | Joint hemorrhage (HP:0005261) | 2.82957818 |
| 20 | Shallow orbits (HP:0000586) | 2.80111260 |
| 21 | Abnormality of glycolipid metabolism (HP:0010969) | 2.76264349 |
| 22 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.76264349 |
| 23 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.76264349 |
| 24 | Osteolytic defects of the hand bones (HP:0009699) | 2.75553716 |
| 25 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.75553716 |
| 26 | Abnormality of complement system (HP:0005339) | 2.74877512 |
| 27 | Recurrent bacterial skin infections (HP:0005406) | 2.72710443 |
| 28 | Glomerulonephritis (HP:0000099) | 2.72003948 |
| 29 | Vascular tortuosity (HP:0004948) | 2.70358332 |
| 30 | Abnormality of the common coagulation pathway (HP:0010990) | 2.69505693 |
| 31 | Mitral valve prolapse (HP:0001634) | 2.58824453 |
| 32 | Cervical subluxation (HP:0003308) | 2.52740940 |
| 33 | Arterial tortuosity (HP:0005116) | 2.50372982 |
| 34 | Gastrointestinal infarctions (HP:0005244) | 2.50226948 |
| 35 | Atrophic scars (HP:0001075) | 2.49436659 |
| 36 | Xanthomatosis (HP:0000991) | 2.42574235 |
| 37 | Dilatation of the ascending aorta (HP:0005111) | 2.40608777 |
| 38 | Gingival bleeding (HP:0000225) | 2.39330748 |
| 39 | Spondylolisthesis (HP:0003302) | 2.38288853 |
| 40 | Cellulitis (HP:0100658) | 2.38133425 |
| 41 | Myositis (HP:0100614) | 2.36725105 |
| 42 | Increased IgE level (HP:0003212) | 2.36540137 |
| 43 | Arterial thrombosis (HP:0004420) | 2.35779248 |
| 44 | Epistaxis (HP:0000421) | 2.33910348 |
| 45 | Esophageal varix (HP:0002040) | 2.33909209 |
| 46 | Nephritis (HP:0000123) | 2.33604347 |
| 47 | Retrobulbar optic neuritis (HP:0100654) | 2.27395100 |
| 48 | Optic neuritis (HP:0100653) | 2.27395100 |
| 49 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.23275117 |
| 50 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.23275117 |
| 51 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.23275117 |
| 52 | Emphysema (HP:0002097) | 2.20007428 |
| 53 | Asymmetry of the thorax (HP:0001555) | 2.18317867 |
| 54 | Increased variability in muscle fiber diameter (HP:0003557) | 2.17583734 |
| 55 | Pustule (HP:0200039) | 2.17308982 |
| 56 | Increased connective tissue (HP:0009025) | 2.17305092 |
| 57 | Recurrent fungal infections (HP:0002841) | 2.16682217 |
| 58 | Pulmonary embolism (HP:0002204) | 2.14336587 |
| 59 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.13172049 |
| 60 | Recurrent skin infections (HP:0001581) | 2.10380573 |
| 61 | Abnormality of macrophages (HP:0004311) | 2.09617444 |
| 62 | Mitral stenosis (HP:0001718) | 2.08719785 |
| 63 | Gingivitis (HP:0000230) | 2.08367369 |
| 64 | Fragile skin (HP:0001030) | 2.08157150 |
| 65 | Follicular hyperkeratosis (HP:0007502) | 2.07994789 |
| 66 | Thoracic kyphosis (HP:0002942) | 2.07729047 |
| 67 | Aneurysm (HP:0002617) | 2.06871190 |
| 68 | Abnormality of the nasal mucosa (HP:0000433) | 2.06501162 |
| 69 | Wormian bones (HP:0002645) | 2.05610630 |
| 70 | Orchitis (HP:0100796) | 2.05360413 |
| 71 | Vacuolated lymphocytes (HP:0001922) | 2.03273930 |
| 72 | Prolonged bleeding time (HP:0003010) | 2.03198165 |
| 73 | Ulnar bowing (HP:0003031) | 2.02455397 |
| 74 | Autoimmune thrombocytopenia (HP:0001973) | 2.02048134 |
| 75 | Persistence of primary teeth (HP:0006335) | 2.01086580 |
| 76 | Syringomyelia (HP:0003396) | 2.00782450 |
| 77 | Spinal cord lesions (HP:0100561) | 2.00782450 |
| 78 | Recurrent cutaneous fungal infections (HP:0011370) | 2.00698724 |
| 79 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.00698724 |
| 80 | Meningitis (HP:0001287) | 2.00378204 |
| 81 | Slender build (HP:0001533) | 1.99834311 |
| 82 | Prolonged partial thromboplastin time (HP:0003645) | 1.98918803 |
| 83 | Menorrhagia (HP:0000132) | 1.98877902 |
| 84 | Recurrent viral infections (HP:0004429) | 1.98003480 |
| 85 | Vasculitis (HP:0002633) | 1.97947304 |
| 86 | Amyloidosis (HP:0011034) | 1.97250287 |
| 87 | Disproportionate tall stature (HP:0001519) | 1.95685823 |
| 88 | Blue sclerae (HP:0000592) | 1.95604709 |
| 89 | Increased cerebral lipofuscin (HP:0011813) | 1.95080595 |
| 90 | Pulmonary infiltrates (HP:0002113) | 1.93135835 |
| 91 | Abnormal platelet volume (HP:0011876) | 1.92925363 |
| 92 | Hemoptysis (HP:0002105) | 1.92717332 |
| 93 | Impaired platelet aggregation (HP:0003540) | 1.91969512 |
| 94 | Abnormal platelet function (HP:0011869) | 1.91969512 |
| 95 | Chronic otitis media (HP:0000389) | 1.91128555 |
| 96 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.89660026 |
| 97 | Loss of speech (HP:0002371) | 1.89653650 |
| 98 | Vertebral compression fractures (HP:0002953) | 1.89367368 |
| 99 | Obstructive lung disease (HP:0006536) | 1.89066344 |
| 100 | Chronic obstructive pulmonary disease (HP:0006510) | 1.89066344 |
| 101 | Inflammation of the large intestine (HP:0002037) | 1.88570426 |
| 102 | Alopecia of scalp (HP:0002293) | 1.88501026 |
| 103 | Soft skin (HP:0000977) | 1.87689144 |
| 104 | Gastrointestinal inflammation (HP:0004386) | 1.87232940 |
| 105 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.86558129 |
| 106 | Mucopolysacchariduria (HP:0008155) | 1.86558129 |
| 107 | Increased mean platelet volume (HP:0011877) | 1.86214917 |
| 108 | Thrombophlebitis (HP:0004418) | 1.85987440 |
| 109 | Dysostosis multiplex (HP:0000943) | 1.85711193 |
| 110 | Bruising susceptibility (HP:0000978) | 1.85202280 |
| 111 | Hemorrhage of the eye (HP:0011885) | 1.85125336 |
| 112 | Abnormality of the lumbar spine (HP:0100712) | 1.85120569 |
| 113 | Striae distensae (HP:0001065) | 1.85026717 |
| 114 | Polycythemia (HP:0001901) | 1.84938993 |
| 115 | Abnormality of the peritoneum (HP:0002585) | 1.84690842 |
| 116 | Genu recurvatum (HP:0002816) | 1.84507606 |
| 117 | Thick nail (HP:0001805) | 1.83269304 |
| 118 | Colitis (HP:0002583) | 1.82839919 |
| 119 | Keratoconjunctivitis sicca (HP:0001097) | 1.82739563 |
| 120 | Mediastinal lymphadenopathy (HP:0100721) | 1.82666299 |
| 121 | Bladder diverticulum (HP:0000015) | 1.82493252 |
| 122 | T lymphocytopenia (HP:0005403) | 1.82401121 |
| 123 | Wrist flexion contracture (HP:0001239) | 1.80731423 |
| 124 | Broad face (HP:0000283) | 1.80120400 |
| 125 | Ectopia lentis (HP:0001083) | 1.79448194 |
| 126 | Interstitial pulmonary disease (HP:0006530) | 1.78977779 |
| 127 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.78007444 |
| 128 | Malnutrition (HP:0004395) | 1.77621598 |
| 129 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.77462100 |
| 130 | Joint stiffness (HP:0001387) | 1.76639553 |
| 131 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.76368769 |
| 132 | Polygenic inheritance (HP:0010982) | 1.75935452 |
| 133 | Abnormality of the thoracic spine (HP:0100711) | 1.75496997 |
| 134 | Lymphangioma (HP:0100764) | 1.75283965 |
| 135 | Camptodactyly of toe (HP:0001836) | 1.74629733 |
| 136 | Thin bony cortex (HP:0002753) | 1.74467000 |
| 137 | Obstructive sleep apnea (HP:0002870) | 1.74244987 |
| 138 | Joint laxity (HP:0001388) | 1.73527068 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 3.67621850 |
| 2 | PKN2 | 3.35501280 |
| 3 | PRPF4B | 3.22524117 |
| 4 | TGFBR2 | 2.97122933 |
| 5 | ERN1 | 2.89172938 |
| 6 | RIPK1 | 2.63104714 |
| 7 | TTN | 2.31761669 |
| 8 | TYK2 | 2.29308563 |
| 9 | SIK1 | 2.11959629 |
| 10 | TAOK3 | 2.09964420 |
| 11 | EPHB1 | 2.01214073 |
| 12 | MAP3K13 | 2.00454437 |
| 13 | PTK6 | 1.97952099 |
| 14 | KIT | 1.97132708 |
| 15 | FGFR4 | 1.96719907 |
| 16 | JAK1 | 1.74724143 |
| 17 | MAP4K1 | 1.74390773 |
| 18 | MAP2K3 | 1.74390485 |
| 19 | CAMK1D | 1.73750862 |
| 20 | JAK3 | 1.70664500 |
| 21 | STK10 | 1.69933725 |
| 22 | EEF2K | 1.67744626 |
| 23 | TBK1 | 1.64036119 |
| 24 | PDGFRA | 1.62326277 |
| 25 | CDC42BPA | 1.59690030 |
| 26 | FGFR2 | 1.49658418 |
| 27 | LATS1 | 1.46535737 |
| 28 | FGFR3 | 1.43106764 |
| 29 | MAP3K14 | 1.41791180 |
| 30 | LRRK2 | 1.40948029 |
| 31 | MAP3K10 | 1.37254996 |
| 32 | SMG1 | 1.33598566 |
| 33 | FLT3 | 1.32323516 |
| 34 | CSK | 1.31749606 |
| 35 | EPHA3 | 1.31483801 |
| 36 | ZAP70 | 1.30682015 |
| 37 | STK3 | 1.26916496 |
| 38 | IRAK3 | 1.26797237 |
| 39 | KDR | 1.25741551 |
| 40 | FRK | 1.24797265 |
| 41 | BLK | 1.16562142 |
| 42 | JAK2 | 1.15285153 |
| 43 | NEK9 | 1.14858389 |
| 44 | TIE1 | 1.13741467 |
| 45 | CAMK1G | 1.12708614 |
| 46 | ICK | 1.12633775 |
| 47 | KSR2 | 1.12192297 |
| 48 | MAP3K1 | 1.11293904 |
| 49 | IKBKE | 1.10389320 |
| 50 | MAP3K6 | 1.09990897 |
| 51 | ITK | 1.08953642 |
| 52 | PAK4 | 1.08546124 |
| 53 | PDGFRB | 1.06835119 |
| 54 | IRAK4 | 1.06756639 |
| 55 | MAP3K3 | 1.05629981 |
| 56 | MARK2 | 1.05353568 |
| 57 | PRKD2 | 1.02715700 |
| 58 | HCK | 1.02619648 |
| 59 | CDK6 | 0.98203635 |
| 60 | BTK | 0.96983799 |
| 61 | DDR2 | 0.95257720 |
| 62 | TRPM7 | 0.94857273 |
| 63 | PDPK1 | 0.94775264 |
| 64 | MST1R | 0.94372053 |
| 65 | IKBKB | 0.92743450 |
| 66 | SYK | 0.88980316 |
| 67 | CLK1 | 0.85859372 |
| 68 | BMX | 0.84435692 |
| 69 | TEC | 0.81953598 |
| 70 | MOS | 0.81327603 |
| 71 | CSF1R | 0.80552721 |
| 72 | TXK | 0.80307390 |
| 73 | TNK2 | 0.79838992 |
| 74 | CDK12 | 0.79711552 |
| 75 | PAK2 | 0.78855912 |
| 76 | TGFBR1 | 0.78637707 |
| 77 | PDK1 | 0.76394826 |
| 78 | PTK2 | 0.74785415 |
| 79 | FGR | 0.74723989 |
| 80 | TAOK2 | 0.73725950 |
| 81 | DMPK | 0.73447735 |
| 82 | HIPK2 | 0.73323316 |
| 83 | STK38 | 0.71037129 |
| 84 | CHUK | 0.70370061 |
| 85 | LCK | 0.69806905 |
| 86 | MAPK11 | 0.68781870 |
| 87 | SIK2 | 0.67923794 |
| 88 | MAP3K7 | 0.67187860 |
| 89 | RPS6KA4 | 0.66410096 |
| 90 | MELK | 0.65479481 |
| 91 | MAP3K2 | 0.64431441 |
| 92 | GRK6 | 0.62879549 |
| 93 | CDK4 | 0.62577287 |
| 94 | MARK3 | 0.61388189 |
| 95 | IRAK1 | 0.61365787 |
| 96 | RIPK4 | 0.61073434 |
| 97 | PRKG2 | 0.60794917 |
| 98 | FES | 0.60207545 |
| 99 | RPS6KL1 | 0.59698847 |
| 100 | RPS6KC1 | 0.59698847 |
| 101 | NLK | 0.58851326 |
| 102 | MTOR | 0.58755777 |
| 103 | MATK | 0.54102167 |
| 104 | EGFR | 0.53453225 |
| 105 | PRKAA2 | 0.52868173 |
| 106 | PIK3CG | 0.52531959 |
| 107 | MAPK7 | 0.51985938 |
| 108 | PTK2B | 0.51828606 |
| 109 | PIM1 | 0.50542330 |
| 110 | MAPK12 | 0.50218694 |
| 111 | GRK7 | 0.50109568 |
| 112 | YES1 | 0.49427025 |
| 113 | SCYL2 | 0.49300288 |
| 114 | MAPK4 | 0.48750827 |
| 115 | FGFR1 | 0.48554285 |
| 116 | SGK3 | 0.48349666 |
| 117 | ABL1 | 0.48087436 |
| 118 | TAOK1 | 0.47531053 |
| 119 | STK4 | 0.42406434 |
| 120 | RET | 0.41688835 |
| 121 | LYN | 0.41485211 |
| 122 | CDK9 | 0.40822645 |
| 123 | IRAK2 | 0.39678705 |
| 124 | MYLK | 0.39562517 |
| 125 | GSK3A | 0.39374882 |
| 126 | MAP3K11 | 0.38914381 |
| 127 | RPS6KA6 | 0.38740279 |
| 128 | IGF1R | 0.38573563 |
| 129 | RPS6KA2 | 0.38082124 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.56364285 |
| 2 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.64276627 |
| 3 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.63274956 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.06836874 |
| 5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.96760983 |
| 6 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.95630199 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.78608466 |
| 8 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.77413519 |
| 9 | Malaria_Homo sapiens_hsa05144 | 1.76381562 |
| 10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.71764465 |
| 11 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.57216259 |
| 12 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.56503749 |
| 13 | Pertussis_Homo sapiens_hsa05133 | 1.50612913 |
| 14 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.45261530 |
| 15 | Allograft rejection_Homo sapiens_hsa05330 | 1.44853311 |
| 16 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.37426712 |
| 17 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.36978858 |
| 18 | Amoebiasis_Homo sapiens_hsa05146 | 1.34424827 |
| 19 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.33399171 |
| 20 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.33111494 |
| 21 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.31714958 |
| 22 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.30730758 |
| 23 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.30108065 |
| 24 | ABC transporters_Homo sapiens_hsa02010 | 1.24901019 |
| 25 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.23838063 |
| 26 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.23632937 |
| 27 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.22970800 |
| 28 | Lysine degradation_Homo sapiens_hsa00310 | 1.22696481 |
| 29 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.22616671 |
| 30 | Focal adhesion_Homo sapiens_hsa04510 | 1.22448875 |
| 31 | Measles_Homo sapiens_hsa05162 | 1.20587199 |
| 32 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.20052047 |
| 33 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.19494225 |
| 34 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.17544698 |
| 35 | Platelet activation_Homo sapiens_hsa04611 | 1.10530608 |
| 36 | Tuberculosis_Homo sapiens_hsa05152 | 1.09711346 |
| 37 | Lysosome_Homo sapiens_hsa04142 | 1.09408782 |
| 38 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.09225328 |
| 39 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.08739265 |
| 40 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.06848402 |
| 41 | Insulin resistance_Homo sapiens_hsa04931 | 1.05747502 |
| 42 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.05383688 |
| 43 | Viral myocarditis_Homo sapiens_hsa05416 | 1.04384490 |
| 44 | Other glycan degradation_Homo sapiens_hsa00511 | 1.02207452 |
| 45 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.98369897 |
| 46 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.98067450 |
| 47 | Influenza A_Homo sapiens_hsa05164 | 0.97575644 |
| 48 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.96010864 |
| 49 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.95958536 |
| 50 | Legionellosis_Homo sapiens_hsa05134 | 0.95835168 |
| 51 | Prion diseases_Homo sapiens_hsa05020 | 0.95756677 |
| 52 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.95194002 |
| 53 | Apoptosis_Homo sapiens_hsa04210 | 0.94085813 |
| 54 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.93121629 |
| 55 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.92573151 |
| 56 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.92177592 |
| 57 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.91620842 |
| 58 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.90602317 |
| 59 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.90053948 |
| 60 | Hepatitis B_Homo sapiens_hsa05161 | 0.87740148 |
| 61 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.87250741 |
| 62 | Asthma_Homo sapiens_hsa05310 | 0.85198385 |
| 63 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.84788000 |
| 64 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.84457078 |
| 65 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.84437319 |
| 66 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.84004895 |
| 67 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.81036699 |
| 68 | Histidine metabolism_Homo sapiens_hsa00340 | 0.79350085 |
| 69 | Hepatitis C_Homo sapiens_hsa05160 | 0.78923573 |
| 70 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.78910020 |
| 71 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.78758710 |
| 72 | Endometrial cancer_Homo sapiens_hsa05213 | 0.78667649 |
| 73 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.77661430 |
| 74 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.76847024 |
| 75 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.76558988 |
| 76 | Shigellosis_Homo sapiens_hsa05131 | 0.74403188 |
| 77 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.73765628 |
| 78 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.73629077 |
| 79 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.73216382 |
| 80 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.72999497 |
| 81 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.72641138 |
| 82 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.72057743 |
| 83 | Adherens junction_Homo sapiens_hsa04520 | 0.70263928 |
| 84 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.70167309 |
| 85 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.69528406 |
| 86 | Bile secretion_Homo sapiens_hsa04976 | 0.69308858 |
| 87 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.68749132 |
| 88 | Glioma_Homo sapiens_hsa05214 | 0.67771073 |
| 89 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.66293178 |
| 90 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.65246441 |
| 91 | Salmonella infection_Homo sapiens_hsa05132 | 0.64606571 |
| 92 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.64325749 |
| 93 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.64152779 |
| 94 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.62644634 |
| 95 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.62292543 |
| 96 | Endocytosis_Homo sapiens_hsa04144 | 0.62290206 |
| 97 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.62269315 |
| 98 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.61740155 |
| 99 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.60711866 |
| 100 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.60253014 |
| 101 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.60243307 |
| 102 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.60084294 |
| 103 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.59248337 |
| 104 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.55980003 |
| 105 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.55611700 |
| 106 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.55531176 |
| 107 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.55435981 |
| 108 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.55352239 |
| 109 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.55181977 |
| 110 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.54927463 |
| 111 | Phagosome_Homo sapiens_hsa04145 | 0.54412257 |
| 112 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.54238977 |
| 113 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.54213010 |
| 114 | Bladder cancer_Homo sapiens_hsa05219 | 0.53824766 |
| 115 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.53703591 |
| 116 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.53212292 |
| 117 | Colorectal cancer_Homo sapiens_hsa05210 | 0.53133856 |
| 118 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.52845018 |
| 119 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.52328712 |
| 120 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.51773023 |
| 121 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.51430412 |
| 122 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.51255956 |
| 123 | Thyroid cancer_Homo sapiens_hsa05216 | 0.50262739 |
| 124 | Peroxisome_Homo sapiens_hsa04146 | 0.49724871 |
| 125 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.49503463 |
| 126 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.49479055 |
| 127 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.47859513 |
| 128 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.47403410 |
| 129 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.46809539 |
| 130 | Prostate cancer_Homo sapiens_hsa05215 | 0.45874403 |
| 131 | HTLV-I infection_Homo sapiens_hsa05166 | 0.44177260 |
| 132 | Retinol metabolism_Homo sapiens_hsa00830 | 0.43526284 |

